{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:13:47Z","timestamp":1648750427430},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/s11914-996-0002-9","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T22:22:25Z","timestamp":1180131745000},"page":"91-97","source":"Crossref","is-referenced-by-count":5,"title":["Bone remodeling markers: Assessment of fracture risk and fracture risk reduction"],"prefix":"10.1007","volume":"1","author":[{"given":"Aubrey","family":"Blumsohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0945-053X(98)90064-6","volume":"16","author":"DJ Prockop","year":"1998","unstructured":"Prockop DJ: What holds us together? Why do some of us fall apart? What can we do about it? Matrix Biol 1998, 16:519\u2013528.","journal-title":"Matrix Biol"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/clinchem\/44.11.2281","volume":"44","author":"C Rosenquist","year":"1998","unstructured":"Rosenquist C, Fledelius C, Christgau S, et al.: Serum crosslaps one step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 1998, 44:2281\u20132289.","journal-title":"Clin Chem"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00223-001-2122-7","volume":"71","author":"JM Halleen","year":"2002","unstructured":"Halleen JM, Ylipahkala H, Alatalo SL, et al.: Serum tartrateresistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int 2002, 71:20\u201325.","journal-title":"Calcif Tissue Int"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/clinchem\/42.6.947","volume":"42","author":"J Melkko","year":"1996","unstructured":"Melkko J, Kauppila S, Niemi S, et al.: Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996, 42:947\u2013954.","journal-title":"Clin Chem"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","volume":"47","author":"P Garnero","year":"2001","unstructured":"Garnero P, Borel O, Delmas PD: Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 2001, 47:694\u2013702.","journal-title":"Clin Chem"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/clinchem\/44.10.2126","volume":"44","author":"TG Rosano","year":"1998","unstructured":"Rosano TG, Peaston RT, Bone HG, et al.: Urinary free deoxypyridinoline by chemiluminescence immunoassay: analytical and clinical evaluation. Clin Chem 1998, 44:2126\u20132132.","journal-title":"Clin Chem"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/jbmr.5650091019","volume":"9","author":"SP Robins","year":"1994","unstructured":"Robins SP, Woitge H, Hesley R, et al.: Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994, 9:1643\u20131649.","journal-title":"J Bone Miner Res"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","volume":"7","author":"DA Hanson","year":"1992","unstructured":"Hanson DA, Weis MA, Bollen AM, et al.: A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992, 7:1251\u20131258.","journal-title":"J Bone Miner Res"},{"key":"2_CR9","first-page":"864","volume":"80","author":"M Bonde","year":"1995","unstructured":"Bonde M, Qvist P, Fledelius C, et al.: Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995, 80:864\u2013868.","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1359\/jbmr.1997.12.1.59","volume":"12","author":"R Eastell","year":"1997","unstructured":"Eastell R, Colwell A, Hampton L, Reeve J: Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res 1997, 12:59\u201365.","journal-title":"J Bone Miner Res"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2265.1994.tb03019.x","volume":"40","author":"A Blumsohn","year":"1994","unstructured":"Blumsohn A, Hannon RA, Wrate R, et al.: Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol (Oxf) 1994, 40:663\u2013670.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jbmr.5650100418","volume":"10","author":"P Garnero","year":"1995","unstructured":"Garnero P, Gineyts E, Arbault P, et al.: Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995, 10:641\u2013649.","journal-title":"J Bone Miner Res"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/clinchem\/41.11.1592","volume":"41","author":"A Blumsohn","year":"1995","unstructured":"Blumsohn A, Naylor KE, Assiri AM, Eastell R: Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. Clin Chem 1995, 41:1592\u20131598.","journal-title":"Clin Chem"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1359\/jbmr.2003.18.4.658","volume":"18","author":"KE Naylor","year":"2003","unstructured":"Naylor KE, Jackson B, Eastell R: The renal clearance of free and peptide-bound deoxypyridinoline: response to pamidronate treatment of Paget\u2019s disease. J Bone Miner Res 2003, 18:658\u2013661.","journal-title":"J Bone Miner Res"},{"key":"2_CR15","first-page":"1693","volume":"79","author":"P Garnero","year":"1994","unstructured":"Garnero P, Shih WJ, Gineyts E, et al.: Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994, 79:1693\u20131700.","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/000456329703400501","volume":"34","author":"A Blumsohn","year":"1997","unstructured":"Blumsohn A, Eastell R: The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice? Ann Clin Biochem 1997, 34:449\u2013459.","journal-title":"Ann Clin Biochem"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S8756-3282(02)00728-7","volume":"30","author":"JA Clowes","year":"2002","unstructured":"Clowes JA, Hannon RA, Yap TS, et al.: Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 2002, 30:886\u2013890.","journal-title":"Bone"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00298992","volume":"57","author":"M Pedrazzoni","year":"1995","unstructured":"Pedrazzoni M, Alfano FS, Gatti C, et al.: Acute effects of bisphosphonates on new and traditional markers of bone resorption. Calcif Tissue Int 1995, 57:25\u201329.","journal-title":"Calcif Tissue Int"},{"key":"2_CR19","first-page":"3537","volume":"85","author":"SL Greenspan","year":"2000","unstructured":"Greenspan SL, Rosen HN, Parker RA: Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women. J Clin Endocrinol Metab 2000, 85:3537\u20133540.","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1359\/jbmr.2003.18.5.859","volume":"18","author":"P Garnero","year":"2003","unstructured":"Garnero P, Ferreras M, Karsdal MA, et al.: The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 2003, 18:859\u2013867.","journal-title":"J Bone Miner Res"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.2002.17.5.826","volume":"17","author":"P Garnero","year":"2002","unstructured":"Garnero P, Cloos P, Sornay-Rendu E, et al.: Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. J Bone Miner Res 2002, 17:826\u2013833.","journal-title":"J Bone Miner Res"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002239900497","volume":"63","author":"BJ Gertz","year":"1998","unstructured":"Gertz BJ, Clemens JD, Holland SD, et al.: Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int 1998, 63:102\u2013106.","journal-title":"Calcif Tissue Int"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S8756-3282(00)00368-9","volume":"27","author":"GW Oddie","year":"2000","unstructured":"Oddie GW, Schenk G, Angel NZ, et al.: Structure, function, and regulation of tartrate-resistant acid phosphatase. Bone 2000, 27:575\u2013584.","journal-title":"Bone"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.2000.15.7.1337","volume":"15","author":"JM Halleen","year":"2000","unstructured":"Halleen JM, Alatalo SL, Suominen H, et al.: Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 2000, 15:1337\u20131345.","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"2_CR25","first-page":"S55","volume":"13","author":"RA Hannon","year":"2002","unstructured":"Hannon RA, Clowes JA, Eagleton AC, et al.: Clinical evaluation of a novel activity-based immunoassay for tartrate resistant acid phosphate (TRACP) isoform 5b. Osteoporos Int 2002, 13(Suppl 1):S55.","journal-title":"Osteoporos Int"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/clinchem\/43.11.2052","volume":"43","author":"CP Price","year":"1997","unstructured":"Price CP, Milligan TP, Darte C: Direct comparison of performance characteristics of two immunoassays for bone isoform of alkaline phosphatase in serum. Clin Chem 1997, 43:2052\u20132057.","journal-title":"Clin Chem"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/000456320003700402","volume":"37","author":"AJ Lee","year":"2000","unstructured":"Lee AJ, Hodges S, Eastell R: Measurement of osteocalcin. Ann Clin Biochem 2000, 37:432\u2013446.","journal-title":"Ann Clin Biochem"},{"key":"2_CR28","first-page":"73","volume-title":"Bone Markers, Biochemical and Clinical Perspectives","author":"J Brandt","year":"2001","unstructured":"Brandt J, Frederiksen JK, Jensen CH, Teisner B: The N- and C-terminal propeptides of human procollagen type I (PINP and PICP): molecular heterogeneity and assay technology. In Bone Markers, Biochemical and Clinical Perspectives. Edited by Eastell et al. London: Martin Dunitz; 2001:73\u201382."},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","volume":"13","author":"RA Hannon","year":"1998","unstructured":"Hannon RA, Blumsohn A, Naylor K, Eastell R: Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 1998, 13:1124\u20131133.","journal-title":"J Bone Miner Res"},{"issue":"Suppl 6","key":"2_CR30","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1007\/s001980070004","volume":"11","author":"R Hannon","year":"2000","unstructured":"Hannon R, Eastell R: Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int 2000, 11(Suppl 6):S30-S44.","journal-title":"Osteoporos Int"},{"key":"2_CR31","first-page":"159","volume-title":"Bone Markers, Biochemical and Clinical Perspectives","author":"A Blumsohn","year":"2001","unstructured":"Blumsohn A: The use of biochemical markers of bone turnover to monitor response to therapy: statistics and logic. In Bone Markers, Biochemical and Clinical Perspectives. Edited by Eastell et al. London:Martin Dunitz; 2001:159\u2013166."},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s001980070088","volume":"11","author":"AC Looker","year":"2000","unstructured":"Looker AC, Bauer DC, Chesnut CH, et al.: Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 2000, 11:467\u2013480.","journal-title":"Osteoporos Int"},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/clinchem\/47.8.1443","volume":"47","author":"MJ Seibel","year":"2001","unstructured":"Seibel MJ, Lang M, Geilenkeuser WJ: Interlaboratory variation of biochemical markers of bone turnover. Clin Chem 2001, 47:1443\u20131450.","journal-title":"Clin Chem"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1359\/jbmr.2000.15.12.2443","volume":"15","author":"HW Woitge","year":"2000","unstructured":"Woitge HW, Knothe A, Witte K, et al.: Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res 2000, 15:2443\u20132450.","journal-title":"J Bone Miner Res"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s001980170122","volume":"12","author":"R Patel","year":"2001","unstructured":"Patel R, Collins D, Bullock S, et al.: The effect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked crossover study. Osteoporos Int 2001, 12:319\u2013325.","journal-title":"Osteoporos Int"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1359\/jbmr.2003.18.7.1274","volume":"18","author":"A Blumsohn","year":"2003","unstructured":"Blumsohn A, Naylor KE, Timm W, et al.: Absence of marked seasonal change in bone turnover: a longitudinal and multicenter cross-sectional study. J Bone Miner Res 2003, 18:1274\u20131281.","journal-title":"J Bone Miner Res"},{"key":"2_CR37","first-page":"730","volume":"79","author":"A Blumsohn","year":"1994","unstructured":"Blumsohn A, Herrington K, Hannon RA, et al.: The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 1994, 79:730\u2013735.","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S8756-3282(02)00791-3","volume":"31","author":"P Qvist","year":"2002","unstructured":"Qvist P, Christgau S, Pedersen BJ, et al.: Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 2002, 31:57\u201361. One of the first studies showing that the circadian rhythm of bone resorption in humans is likely to be driven by food intake.","journal-title":"Bone"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00223-001-0010-9","volume":"68","author":"V Zikan","year":"2001","unstructured":"Zikan V, Haas T, Stepan JJ: Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum beta-CrossLaps. Calcif Tissue Int 2001, 68:352\u2013357.","journal-title":"Calcif Tissue Int"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S8756-3282(01)00662-7","volume":"30","author":"NH Bjarnason","year":"2002","unstructured":"Bjarnason NH, Henriksen EE, Alexandersen P, et al.: Mechanism of circadian variation in bone resorption. Bone 2002, 30:307\u2013313.","journal-title":"Bone"},{"key":"2_CR41","unstructured":"Clowes JA, Allen HC, Prentis D, et al.: Effect of octreotide on bone turnover and parathyroid hormone after oral glucose: evidence for a novel endocrine interaction between the gastrointestinal tract and bone. J Bone Miner Res 2002: S1165."},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Hausherr E, Chapuy MC, et al.: Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996, 11:1531\u20131538.","journal-title":"J Bone Miner Res"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S8756-3282(00)00325-2","volume":"27","author":"RD Chapurlat","year":"2000","unstructured":"Chapurlat RD, Garnero P, Breart G, et al.: Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 2000, 27:283\u2013286.","journal-title":"Bone"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.312.7029.482","volume":"312","author":"PL Daele van","year":"1996","unstructured":"van Daele PL, Seibel MJ, Burger H, et al.: Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ 1996, 312:482\u2013483.","journal-title":"BMJ"},{"key":"2_CR45","first-page":"219","volume-title":"Bone Markers, Biochemical and Clinical Perspectives","author":"DC Bauer","year":"2001","unstructured":"Bauer DC: Biochemical markers of bone turnover: the study of osteoporotic fracture. In Bone Markers, Biochemical and Clinical Perspectives. Edited by Eastell et al. London: Martin Dunitz; 2001:219\u2013236."},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","volume":"18","author":"R Eastell","year":"2003","unstructured":"Eastell R, Barton I, Hannon RA, et al.: Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 2003, 18:1051\u20131056. This study demonstrates that change in bone turnover after bisphosphonate therapy may be a better predictor of fracture risk reduction than change in BMD. Also discusses the possible mechanisms underlying a direct effect of change in bone turnover on fracture risk.","journal-title":"J Bone Miner Res"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s001980170020","volume":"12","author":"NH Bjarnason","year":"2001","unstructured":"Bjarnason NH, Sarkar S, Duong T, et al.: Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis. Osteoporos Int 2001, 12:922\u2013930.","journal-title":"Osteoporos Int"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s001980200101","volume":"13","author":"RD Chapurlat","year":"2002","unstructured":"Chapurlat RD, Cummings SR: Does follow-up of osteoporotic women treated with antiresorptive therapies improve effectiveness? Osteoporos Int 2002, 13:738\u2013744.","journal-title":"Osteoporos Int"},{"key":"2_CR49","first-page":"10","volume":"9","author":"RA Hannon","year":"2003","unstructured":"Hannon RA, Eastell R: Biochemical markers of bone turnover and fracture prediction. J Br Menopause Soc 2003, 9:10\u201315.","journal-title":"J Br Menopause Soc"},{"issue":"Suppl 6","key":"2_CR50","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s001980070006","volume":"11","author":"P Garnero","year":"2000","unstructured":"Garnero P: Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 2000, 11(Suppl 6):S55-S65.","journal-title":"Osteoporos Int"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF01321832","volume":"53","author":"K Akesson","year":"1993","unstructured":"Akesson K, Vergnaud P, Gineyts E, et al.: Impairment of bone turnover in elderly women with hip fracture. Calcif Tissue Int 1993, 53:162\u2013169.","journal-title":"Calcif Tissue Int"},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00301599","volume":"56","author":"CK Cheung","year":"1995","unstructured":"Cheung CK, Panesar NS, Lau E, et al.: Increased bone resorption and decreased bone formation in Chinese patients with hip fracture. Calcif Tissue Int 1995, 56:347\u2013349.","journal-title":"Calcif Tissue Int"},{"key":"2_CR53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0009-8981(01)00742-2","volume":"316","author":"K Kawana","year":"2002","unstructured":"Kawana K, Takahashi M, Hoshino H, Kushida K: Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis. Clin Chim Acta 2002, 316:109\u2013115.","journal-title":"Clin Chim Acta"},{"key":"2_CR54","first-page":"S84","volume":"18","author":"EV McCloskey","year":"2003","unstructured":"McCloskey EV, Bal S, Jalava T, et al.: Relative importance of BMD, markers of bone turnover, height and body weight as predictors of hip fracture \u2014 a prospective case-control study. J Bone Miner Res 2003, 18:S84.","journal-title":"J Bone Miner Res"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1359\/jbmr.2000.15.9.1835","volume":"15","author":"RD Chapurlat","year":"2000","unstructured":"Chapurlat RD, Garnero P, Breart G, et al.: Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study. J Bone Miner Res 2000, 15:1835\u20131841.","journal-title":"J Bone Miner Res"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s001980050100","volume":"8","author":"P Garnero","year":"1998","unstructured":"Garnero P, Dargent-Molina P, Hans D, et al.: Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study. Osteoporos Int 1998, 8:563\u2013569.","journal-title":"Osteoporos Int"},{"key":"2_CR57","first-page":"719","volume":"82","author":"P Vergnaud","year":"1997","unstructured":"Vergnaud P, Garnero P, Meunier PJ, et al.: Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997, 82:719\u2013724.","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254\u20131259.","journal-title":"BMJ"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(00)00301-X","volume":"27","author":"PD Delmas","year":"2000","unstructured":"Delmas PD: How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? Bone 2000, 27:1\u20133.","journal-title":"Bone"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/jcem.85.1.6267","volume":"85","author":"RD Wasnich","year":"2000","unstructured":"Wasnich RD, Miller PD: Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab 2000, 85:231\u2013236.","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","volume":"17","author":"S Sarkar","year":"2002","unstructured":"Sarkar S, Mitlak BH, Wong M, et al.: Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 2002, 17:1\u201310.","journal-title":"J Bone Miner Res"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","volume":"112","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Karpf DB, Harris F, et al.: Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002, 112:281\u2013289. Meta-analysis of 12 trials to describe the relation between improvement in spine BMD with antiresorptive therapy in relation to fracture risk reduction. Improvement in spine BMD during treatment accounts for a small component of the observed reduction in risk of vertebral fracture.","journal-title":"Am J Med"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"J Reginster","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, et al.: Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000, 11:83\u201391.","journal-title":"Osteoporos Int"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.2002.17.1.11","volume":"17","author":"BL Riggs","year":"2002","unstructured":"Riggs BL, Melton LJ, III: Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 2002, 17:11\u201314.","journal-title":"J Bone Miner Res"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s001980070111","volume":"11","author":"NE Lane","year":"2000","unstructured":"Lane NE, Sanchez S, Genant HK, et al.: Short-term increases in bone turnover markers predict parathyroid hormoneinduced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 2000, 11:434\u2013442.","journal-title":"Osteoporos Int"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-996-0002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-996-0002-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-996-0002-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:23:33Z","timestamp":1587554613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-996-0002-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s11914-996-0002-9","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}